Spectrophotometric and HPLC determination of deflazacort in pharmaceutical dosage forms

Deflazacort (DFZ) is a glucocorticoid used as an anti-inflammatory and immunosuppressant drug. No official methods are available for DFZ determination in pharmaceutical formulations. The objective of this study was to develop, validate and compare spectrophotometric (UV and colorimetric) and high-performance liquid chromatography (HPLC) methods, for the quantitative determination of DFZ in tablets and oral suspension. For the UV method, ethanol was used as the solvent, with detection at 244 nm. The colorimetric method was based on the redox reaction with blue tetrazolium in alkaline medium, with detection at 524 nm. The method by HPLC was carried out using a C18 column, mobile phase consisting of acetonitrile:water (80:20, v/v) with a flow rate of 1.0 mL min-1 and detection at 244 nm. The methods proved linear (r &gt; 0.999), precise (RSD < 5%) and accurate (recovery &gt; 97%). Statistical analysis of the results indicated that the UV and HPLC methods were statistically equivalent, while the values obtained for the colorimetric method differed significantly from the other methods.

Saved in:
Bibliographic Details
Main Authors: Scremin,Amarilis, Piazzon,Monika, Silva,Marcos Antonio Segatto, Kuminek,Gislaine, Correa,Giane Márcia, Paulino,Niraldo, Cardoso,Simone Gonçalves
Format: Digital revista
Language:English
Published: Universidade de São Paulo, Faculdade de Ciências Farmacêuticas 2010
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502010000200015
Tags: Add Tag
No Tags, Be the first to tag this record!